The cell and gene therapy landscape is evolving. Directly editing the genome or subcellular processes isn’t an aspirational dream anymore, but a potentially game-changing class of therapeutics for life-threatening and seriously debilitating diseases. Zeeks was fortunate enough to attend ELRIG’s Cell and Gene Therapy conference in Cambridge, hearing from the scientists developing cell and gene therapies about innovations in development across a plethora of diseases and therape

In life science marketing, this means that a dense data slide or technical abstract rarely makes a lasting impression. To be remembered, your audience’s brain must engage with your message, ideally emotionally, visually, and conceptually. This blog talks about how to create memorable content.

ELRIG is a scientific association that predominantly organises science conferences. It has become a hub for the drug discovery community, from academics to commercial partners and medicine developers, all with a mission to foster open access to modern research and innovation. As a company in the centre of the rapidly changing landscape of drug discovery, including cell and gene therapies, AI in medicine development, and the emerging geographies, we spoke with Sanj Kumar,

In a world where innovation never slows down, the ability to communicate complex research clearly and persuasively is what separates biotech success stories from forgotten projects. At Zeeks, we’ve seen it repeatedly: the biotech companies that win investor trust aren’t always the ones with the most exciting data, but those that can translate lab results into investor-ready stories.

Biotech marketing in 2026 faces AI pressures, layoffs, and funding uncertainty. Discover five shifts helping life science companies connect and lead.

In life science and biotech marketing, your role is not to star in the story. It’s to guide the hero - the researcher, clinician, or innovator - through their journey. Neuroscience tells us this approach is not only more memorable but more persuasive. Numbers show it drives trust and engagement. And practical experience, from projects such as the “Conversations on AFM” podcast, proves it works. The most powerful stories are not about companies. They’re about people.